Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 5, 2010, Pages 1039-1044

  Yang, Deyong ^a   Song, Xishuang ^a   Zhang, Jianing ^a   Ye, Lin ^a   Wang, Shujing ^a   Che, Xiangyu ^a   Wang, Jianbo ^a   Zhang, Zhiwei ^a   Wang, Lina ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bladder cancer; Gene therapy; Livin; Small interfering RNA (siRNA)

Indexed keywords

ANTI-APOPTOTIC FACTOR; APOPTOSIS; APOPTOSIS INDUCTION; APOPTOTIC; APOPTOTIC STIMULI; BLADDER CANCER CELL LINE; BLADDER CANCERS; CANCER CELL LINES; CANCER CELLS; CANCER GENE THERAPY; CASPASE-3; CASPASES; COLONY FORMATION; GROWTH INHIBITION; HUMAN BLADDER CANCER; IN-CELL; INHIBITOR OF APOPTOSIS PROTEINS; MITOMYCIN; PRO-APOPTOTIC STIMULI; SMALL INTERFERING RNA (SIRNA);

CELL CULTURE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; GENE EXPRESSION; GENETIC ENGINEERING; GROWTH KINETICS; RNA;

GENE THERAPY;

BIRC7 PROTEIN, HUMAN; CASPASE; INHIBITOR OF APOPTOSIS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BLADDER TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; URINARY BLADDER NEOPLASMS;

EID: 77955376251     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90934     Document Type: Article

References (31)

1. Kamat AM and Lamm DL, Urology, 55, 161-168 (2000).
2. Kasof GM and Gomes BC, J. Biol. Chem., 276, 3238-3246 (2001).
3. Ma L, Huang Y, Song Z, Feng S, Tian X, Du W, Qiu X, Heese K, and Wu M, Cell Death. Differ., 13, 2079-2088 (2006).
4. Wang L, Zhang Q, Liu B, Han M, and Shan B, Mol. Cancer Ther., 7, 3661-3669 (2008).
5. Kumar S, Cell Death. Differ., 14, 32-43 (2007).
6. Liu B, Han M, Wen JK, and Wang L, Cancer Lett., 250, 168-176 (2007).
7. Crnkovic-Mertens I, Hoppe-Seyler F, and Butz K, Oncogene, 22, 8330-8336 (2003).
8. Wang R, Lin F, Wang X, Gao P, Dong K, Zou AM, Cheng SY, Wei SH, and Zhang HZ, Cancer Gene Ther., 15, 402-412 (2008).
9. Liu HB, Kong CZ, Zeng Y, Liu XK, Bi JB, Jiang YJ, and Han S, Urol. Oncol., 27, 277-283 (2008).
10. Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, and Agliano AM, Ann. Oncol., 14, 85-90 (2003).
11. Fuchs U, mm-Welk C, and Borkhardt A, Curr. Mol. Med., 4, 507-517 (2004).
12. Moazed D, Nature, 457, 413-420 (2009).
13. Kim D and Rossi J, Biotechniques, 44, 613-616 (2008).
14. Fischer U and Schulze-Osthoff K, Pharmacol. Rev., 57, 187-215 (2005).
15. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, and Korneluk RG, Oncogene, 27, 6252-6275 (2008).
16. Wang H, Tan SS, Wang XY, Liu DH, Yu CS, Bai ZL, He DL, and Zhao J, Acta Pharmacol. Sin., 28, 1968-1974 (2007).
17. Fedorov Y, Anderson EM, Birmingham A, Reynolds A, Karpilow J, Robinson K, Leake D, Marshall WS, and Khvorova A, RNA, 12, 1188-1196 (2006).
18. Scherer LJ and Rossi JJ, Nat. Biotechnol., 21, 1457-1465 (2003).
19. Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, Karpilow J, Marshall WS, and Khvorova A, RNA, 12, 988-993 (2006).
20. Franken NA, Rodermond HM, Stap J, Haveman J, and van Bree C, Nat. Protoc., 1, 2315-2319 (2006).
21. Wu KY, Wang HZ, and Hong SJ, Mol. Vis., 14, 1705-1712 (2008).
22. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, and Wu TC, Gene Ther., 13, 464-477 (2006).
23. Wang L, Fuqing Z, Zheng L, and Tong Q, J. Huazhong Univ. Sci. Technolog Med. Sci., 26, 317-318, 328 (2006).
24. Zhao JH, Yang CT, Wu JW, Tsai WB, Lin HY, Fang HW, Ho Y, and Liu HL, J. Biomol. Struct. Dyn., 26, 65-74 (2008).
25. Ashkenazi A, Cytokine Growth Factor Rev., 19, 325-331 (2008).
26. Crnkovic-Mertens I, Semzow J, Hoppe-Seyler F, and Butz K, J. Mol. Med., 84, 232-240 (2006).
27. Ashhab Y, Alian A, Polliack A, Panet A, and Ben YD, FEBS Lett., 495, 56-60 (2001).
28. Hou JQ, He J, Wen DG, and Wang XL, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 24, 401-404 (2007).
29. Bilim V, Kasahara T, Hara N, Takahashi K, and Tomita Y, Int. J. Cancer, 103, 29-37 (2003).
30. Zhao YZ, Luo YK, Lu CT, Xu JF, Mei XG, Wang HJ, and Zhang M, Yao Xue Xue Bao, 42, 1323-1326 (2007).
31. Feril Jr LB, Ogawa R, Tachibana K, and Kondo T, Cancer Sci., 97, 1111-1114 (2006).